Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06262867 · ClinicalTrials.gov registry record · NA

Early Allergen System Experience

A NA study of Food Allergy in Infants, sponsored by Prollergy dba Ready Set Food.

Active
Registry status
NA
Development phase
1,110
Enrollment target
1
Study location

NCT06262867: Active NA study of Food Allergy in Infants, sponsored by Prollergy dba Ready Set Food.

NCT06262867 is a NA study of Food Allergy in Infants that is active but no longer recruiting, run by Prollergy dba Ready Set Food. The registered enrollment target is 1,110 participants, below the 4,758-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06262867, a NA study of Food Allergy in Infants, is active but no longer recruiting, sponsored by Prollergy dba Ready Set Food.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,110 participants
Enrollment target
1
Study location

Study Summary

Multiple clinical trials have demonstrated that early allergen introduction, feeding babies common food allergens before six months, decreases children's risk of developing a food allergy. Despite successful food allergy introduction trials showing that food allergies can be prevented, early introduction in the required amount can be challenging for parents. In some studies, less than 20% of parents introduce peanuts before their child is six months old, and few feed them regularly after introduction. Ready. Set. Food! is a direct-to-consumer product that offers a convenient supplement with a daily dose regimen that can be added to breastmilk, formula, or food to make early allergen introduction easy. The formulation includes cow's milk, egg, and peanut, representing the majority of childhood food allergies, and the protein levels are based on doses found to be effective in clinical trials. Over 200,000 infants have used Ready. Set. Food!. This study investigates the effectiveness of introducing common allergens to infants with the goal of preventing food allergies. The study will enroll 1,100 infants stratified by their risk of developing a food allergy who are assigned to either receive Ready. Set. Food! supplements or follow standard allergen introduction practices recommended by their pediatrician. The goal of this study is to assess how Ready. Set. Food! allergen introduction supplements improve the experience of parents introducing allergens, decrease healthcare costs related to food allergies, and decrease food allergy prevalence.

Primary Outcome

Adherence will be measured using a food frequency questionnaire

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Ready. Set. Food! Stage 1 Mix ins

Study Locations (1)

New York

  • Virtual Site Location - Curavit - New York

Trial Details

FieldValue
Enrollment Target 1,110 participants
Start Date 2024-03-07
Est. Completion 2026-07-01
Phase NA
Prollergy dba Ready Set Food

1 total trials

What the registry record for NCT06262867 still lists

NCT06262867 is an interventional study that assigns participants to a tested intervention. Its 1,110 participants enrollment target places it among the larger protocols in the corpus, below the 4,758-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Food Allergy in Infants appearing as the primary indexed condition, and to 1 intervention - of which Ready. Set. Food! Stage 1 Mix ins is the first listed.

NCT06262867 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06262867 about?

NCT06262867 is a clinical study titled "Early Allergen System Experience". Multiple clinical trials have demonstrated that early allergen introduction, feeding babies common food allergens before six months, decreases children's risk of developing a food allergy. Despite successful food allergy introduction trials showing that food allergies can be prevented, early introdu...

What is the current status of trial NCT06262867?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,110 participants. The study started on 2024-03-07. Estimated completion is 2026-07-01.

What conditions does trial NCT06262867 study?

This clinical trial studies the following conditions: Food Allergy in Infants.

What interventions are being tested in trial NCT06262867?

The interventions under investigation include: Ready. Set. Food! Stage 1 Mix ins (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06262867?

This trial is sponsored by Prollergy dba Ready Set Food, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06262867 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Food Allergy in Infants

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02140255 · 1,120 participants · Phase 1

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • NCT06618534 · 1,120 participants · Phase 2

    Azithromycin for Meningococcal Carriage

  • NCT07164131 · 1,120 participants · Phase 4

    Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

  • NCT00710112 · 1,100 participants

    Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06262867, the US trial registry maintained by the National Library of Medicine. NCT06262867 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.